These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7604148)

  • 1. 5-HT3 agonist-induced dopamine overflow during withdrawal from continuous or intermittent cocaine administration.
    King GR; Xue Z; Calvi C; Ellinwood EH
    Psychopharmacology (Berl); 1995 Feb; 117(4):458-65. PubMed ID: 7604148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of accumbens 5-HT3 receptor down-regulation by ondansetron administered during continuous cocaine administration.
    King GR; Xiong Z; Ellinwood EH
    Eur J Pharmacol; 1999 Jan; 364(2-3):79-87. PubMed ID: 9932709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-HT3 receptor mediated dopamine release in the nucleus accumbens during withdrawal from continuous cocaine.
    Matell MS; King GR
    Psychopharmacology (Berl); 1997 Apr; 130(3):242-8. PubMed ID: 9151358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Withdrawal from continuous cocaine administration: time dependent changes in accumbens 5-HT3 receptor function and behavioral tolerance.
    King GR; Xiong Z; Ellinwood EH
    Psychopharmacology (Berl); 1999 Mar; 142(4):352-9. PubMed ID: 10229059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 5-HT3 receptor agonist 1-(m-chlorophenyl)-biguanide facilitates noradrenaline release by blockade of alpha 2-adrenoceptors in the mouse brain cortex.
    Schlicker E; Kathmann M; Exner HJ; Detzner M; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Jan; 349(1):20-4. PubMed ID: 7908122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detailed investigations of 5-HT3 compounds in a drug discrimination model.
    De La Garza R; Callahan PM; Cunningham KA
    Pharmacol Biochem Behav; 1996 Jul; 54(3):533-40. PubMed ID: 8743626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-HT3 receptor modulation of behavior during withdrawal from continuous or intermittent cocaine.
    King GR; Joyner CM; Ellinwood EH
    Pharmacol Biochem Behav; 1994 Mar; 47(3):399-407. PubMed ID: 8208757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High calcium permeability of serotonin 5-HT3 receptors on presynaptic nerve terminals from rat striatum.
    Rondé P; Nichols RA
    J Neurochem; 1998 Mar; 70(3):1094-103. PubMed ID: 9489730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facilitating role of m-chlorophenylbiguanide in a cocaine discrimination.
    Koetzner L; Mastropaolo J; Deutsch SI
    Pharmacol Biochem Behav; 1995 Dec; 52(4):815-8. PubMed ID: 8587924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine and serotonin release-regulating autoreceptor sensitivity in A9/A10 cell body and terminal areas after withdrawal of rats from continuous infusion of cocaine.
    Chen NH; Reith ME
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1445-53. PubMed ID: 8263807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The characterization of the effect of locally applied N-methylquipazine, a 5-HT3 receptor agonist, on extracellular dopamine levels in the anterior medial prefrontal cortex in the rat: an in vivo microdialysis study.
    Kurata K; Ashby CR; Oberlender R; Tanii Y; Kurachi M; Rini NJ; Strecker RE
    Synapse; 1996 Dec; 24(4):313-21. PubMed ID: 10638822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1-(m-chlorophenyl)-biguanide, a potent high affinity 5-HT3 receptor agonist.
    Kilpatrick GJ; Butler A; Burridge J; Oxford AW
    Eur J Pharmacol; 1990 Jun; 182(1):193-7. PubMed ID: 2144822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Withdrawal from continuous or intermittent cocaine: behavioral responsivity to 5-HT1 receptor agonists.
    King GR; Joyner CM; Ellinwood EH
    Pharmacol Biochem Behav; 1993 Jul; 45(3):577-87. PubMed ID: 8332619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced accumbal dopamine release following 5-HT(2A) receptor stimulation in rats pretreated with intermittent cocaine.
    Yan Q; Reith ME; Yan S
    Brain Res; 2000 Apr; 863(1-2):254-8. PubMed ID: 10773215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presynaptic 5-HT3 receptor-mediated modulation of synaptic GABA release in the mechanically dissociated rat amygdala neurons.
    Koyama S; Matsumoto N; Kubo C; Akaike N
    J Physiol; 2000 Dec; 529 Pt 2(Pt 2):373-83. PubMed ID: 11101647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral effects of the 5-hydroxytryptamine3 receptor agonists 1-phenylbiguanide and m-chlorophenylbiguanide in rats.
    Higgins GA; Joharchi N; Sellers EM
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1440-9. PubMed ID: 8450478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ca2+ permeability of cloned and native 5-hydroxytryptamine type 3 receptors.
    Hargreaves AC; Lummis SC; Taylor CW
    Mol Pharmacol; 1994 Dec; 46(6):1120-8. PubMed ID: 7808432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine efflux during withdrawal from continuous or intermittent cocaine.
    King GR; Kuhn C; Ellinwood EH
    Psychopharmacology (Berl); 1993; 111(2):179-84. PubMed ID: 7870949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential influence of two serotonin 5-HT3 receptor antagonists on spinal serotonin-induced analgesia in rats.
    Bardin L; Jourdan D; Alloui A; Lavarenne J; Eschalier A
    Brain Res; 1997 Aug; 765(2):267-72. PubMed ID: 9313899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin-3 receptor and ethanol-stimulated dopamine release in the nucleus accumbens.
    Campbell AD; McBride WJ
    Pharmacol Biochem Behav; 1995 Aug; 51(4):835-42. PubMed ID: 7675866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.